Luxembourg Approves Key Unified Patent Court Instrument But Uncertainties Continue
Luxembourg will be hosting the UPC’s Court of Appeal and Registry but it is still not clear when or even whether Europe’s new common patent court will be introduced.
You may also be interested in...
Europe’s UPC still cannot start until and unless a legal challenge in Germany is settled in favor of the court, but the UK’s ratification this week means that discussions about the UK’s post-Brexit participation in the new systemcan now start properly.
MSD has agreed to restrict the use of its Keytruda combination therapy in a manner that means that Roche’s Tecentriq combination is no longer a direct comparator.
ERC Belgium has pledged to collect more data to convince the European Medicines Agency that Sitoiganap merits approval. Meanwhile, UGA Biopharma said it would address the agency’s objections over its biosimilar version of eptacog alfa.